Your session is about to expire
← Back to Search
NMES + Mirror Therapy for Wrist Fractures
N/A
Recruiting
Led By Joy MacDermid, PhD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 to 10, and 12 weeks post fracture
Awards & highlights
Study Summary
This trial aims to study how therapies during immobilization of distal radius fractures can improve outcomes and help patients return to their daily activities after fracture.
Who is the study for?
This trial is for individuals who have recently (within the last 3 weeks) suffered a distal radius fracture, are being treated with a cast, and can understand English. They should be able to give informed consent without any cognitive impairments that would limit their understanding of the study.Check my eligibility
What is being tested?
The trial is testing if neuromuscular stimulation (NMES), mirror therapy, or both combined can help minimize negative effects from immobilization due to a wrist fracture. Participants will be divided into four groups: one receiving standard care, one with mirror therapy, another with NMES, and the last group getting both treatments during their immobilization period.See study design
What are the potential side effects?
While not explicitly stated in this summary, potential side effects may include discomfort from NMES treatment such as skin irritation under electrode placement areas or muscle fatigue. Mirror therapy generally has minimal risks but could potentially cause psychological distress or confusion.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6, 8 to 10, and 12 weeks post fracture
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6, 8 to 10, and 12 weeks post fracture
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adherence
Secondary outcome measures
Dexterity
Electromyography (EMG)
EuroQol-5D (EQ-5D)
+12 moreTrial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Neuromuscular Stimulation (NMES)Experimental Treatment1 Intervention
Participants will engage in a home based neuromuscular stimulation intervention from 3 to 6 weeks post-fracture.
Group II: Mirror Therapy + NMESExperimental Treatment1 Intervention
Participants will engage in a home based combined mirror therapy + neuromuscular stimulation intervention from 3 to 6 weeks post-fracture.
Group III: Mirror TherapyExperimental Treatment1 Intervention
Participants will engage in a home based mirror therapy intervention from 3 to 6 weeks post-fracture.
Group IV: Standard of CareActive Control1 Intervention
Participants will follow standard practice protocols at the Roth McFarlane Hand and Upper Limb Centre in London.
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
659 Previous Clinical Trials
413,660 Total Patients Enrolled
Western UniversityOTHER
26 Previous Clinical Trials
128,469 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,345 Previous Clinical Trials
26,453,495 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have vision problems that prevent me from participating in certain physical therapies.I have metal implants in my arm due to an injury.I broke my wrist less than 3 weeks ago and it's in a cast.I understand the information given to me and can make decisions about my health care.My cancer is currently active.I have a clot in a vein of my injured arm.I have severe issues with blood flow in my limbs.
Research Study Groups:
This trial has the following groups:- Group 1: Mirror Therapy + NMES
- Group 2: Standard of Care
- Group 3: Neuromuscular Stimulation (NMES)
- Group 4: Mirror Therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are patients aged 60 or over being admitted to this experiment?
"This research is open to adults aged 18 or over but below the age of 80."
Answered by AI
Who may participate in this research study?
"Individuals seeking to join this trial must have an isolated distal radius fracture and be between 18-80 years old. At present, the study is enrolling around 72 participants."
Answered by AI
Are participants still being accepted for this research study?
"As stated on clinicaltrials.gov, this trial is no longer enrolling participants; it was initially posted July 1st 2023 and the most recent update occured June 27th 2023. Despite that, there are still 370 other trials currently seeking out patient volunteers."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger